IPIX (Innovation Pharmaceuticals) Other Current Payables: $0.02 Mil (As of Sep. 2023)


What is Innovation Pharmaceuticals Other Current Payables?

Innovation Pharmaceuticals IPIX Other Current Payables is $0.02 Mil as of Sep. 2023.

Innovation Pharmaceuticals's Other Current Payables for the quarter that ended in Sep. 2023 was $0.02 Mil.

Innovation Pharmaceuticals's quarterly Other Current Payables declined from Mar. 2023 ($0.02 Mil) to Jun. 2023 ($0.01 Mil) but then increased from Jun. 2023 ($0.01 Mil) to Sep. 2023 ($0.02 Mil).

Innovation Pharmaceuticals's annual Other Current Payables increased from Jun. 2021 ($0.02 Mil) to Jun. 2022 ($0.06 Mil) but then declined from Jun. 2022 ($0.06 Mil) to Jun. 2023 ($0.01 Mil).

Innovation Pharmaceuticals Other Current Payables Related Terms

Innovation Pharmaceuticals Other Current Payables Historical Data

* Premium members only.

The historical data trend for Innovation Pharmaceuticals's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovation Pharmaceuticals Other Current Payables Chart

Innovation Pharmaceuticals Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.01 0.02 0.06 0.01

Innovation Pharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.01 0.02 0.01 0.02

Innovation Pharmaceuticals Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $0.02 Mil mean?
Innovation Pharmaceuticals (IPIX) has a Other Current Payables of $0.02 Mil as of Sep. 2023. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Innovation Pharmaceuticals and its competitors.
Is Innovation Pharmaceuticals' Other Current Payables too high?
Innovation Pharmaceuticals' current Other Current Payables is $0.02 Mil.
How does Innovation Pharmaceuticals' Other Current Payables compare to AXIM and RNAZ?
Innovation Pharmaceuticals' Other Current Payables of $0.02 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Innovation Pharmaceuticals and its competitors. Innovation Pharmaceuticals's current Other Current Payables is $0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovation Pharmaceuticals stock overvalued right now?
Innovation Pharmaceuticals (IPIX) has a current Other Current Payables of $0.02 Mil. The current Other Current Payables is $0.02 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Innovation Pharmaceuticals (IPIX), the current Other Current Payables is $0.02 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovation Pharmaceuticals Business Description

Address 301 Edgewater Place, Suite 100, Wakefield, MA, USA, 01880
Innovation Pharmaceuticals Inc is a clinical-stage pharmaceutical company in the United States. It is engaged in developing therapies with oncology, dermatology, and antimicrobial applications. Its clinical trials focus on evaluating its drug candidates, including Kevetrin for the treatment of cancers; Brilacidin, a potential therapeutic for the treatment of the novel coronavirus. The company focuses on developing small molecule therapies to treat diseases in the areas of cancer, antibiotics, and inflammatory disease.